TheEdgeResearch
Home / Stocks / ETAO

ETAO International Co., Ltd. (ETAO)

NASDAQ Healthcare Medical - Healthcare Information Services
$1.91 ▼ -31.79%
Market Cap
$9.8M
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
1.92
52-Wk Range
1.71-22.0
CEO
Wensheng Liu
Country
US
Currency
USD

ETAO International Co., Ltd. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $1.91, down 31.79% on the session, giving a market capitalisation of $9.8M. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -1544.4%. Its beta of 1.92 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.17
Price / Book
-0.65
EV / EBITDA
-0.02
Gross margin
32.7%
Operating margin
-1269.6%
Net margin
-1544.4%
Return on equity
Debt / equity
-0.99
Current ratio
0.77
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
3,600
IPO date
2021-06-24
Headquarters
New York City, NY, US
About ETAO International Co., Ltd.

ETAO International Co., Ltd., headquartered in New York, is a digital healthcare firm specializing in providing medical services and advanced biomedical technologies to patients throughout China. The company is actively constructing an expansive healthcare ecosystem. This comprehensive network is designed to integrate hospitals, specialized clinics, artificial intelligence and big data-powered diagnostic tools, medical analysis services, biotechnology companies, and an insurance agency, all aimed at ensuring patients have seamless access to medical assistance and a broad spectrum of healthcare services.

Comparable companies

ETAO International Co., Ltd. is most often compared with the following Healthcare names:

APGNCANOCJJDCNTGCYCCFTRPHLTHQIMVIFNUROTNFA
More research on ETAO
ETAO technical analysis ETAO TheEdge Score Compare against peers
Open full interactive analysis & DCF →